Yahoo Suche Web Suche

Anmelden

Suchergebnisse

  1. Suchergebnisse:

  1. www.antarespharma.comHome :: Antares Pharma

    Antares Pharma is a biopharmaceutical company that develops and commercializes products for the treatment of cancer and other diseases. As of May 24, 2022, it has been acquired by Halozyme, a leading drug delivery business, creating a leading drug delivery business with broadly licensable opportunities across the ENHANZE® and Antares’ auto injector technologies.

    • About Antares

      About Antares. Antares Pharma is a specialty pharmaceutical...

    • Medicines

      Antares Pharma Drug Portfolio. Antares Pharma focuses on the...

    • For Partners

      Partnering with Antares Pharma. Antares Pharma actively...

    • For Investors

      Halozyme has completed its acquistion of Antares Pharma,...

    • For Patients

      Antares strives to be recognized by patients as an...

    • Pipeline

      This site ©2024 Antares Pharma. All Rights Reserved. About...

    • Scientific Publications

      Travanty M 1, Calawa B 2, Shalaby W 3, Jozwiakowski M 3,...

    • Drug Safety

      At Antares Pharma, patient safety is exceptionally important...

  2. www.aps-hh.de › klinikversorgungKlinikversorgung - antares-Klinikversorgung

    Langjährige Erfahrung und umfassendes Know-how haben antares pharma service zu einer der ersten Adressen in der Klinikversorgung gemacht. Wir stimmen unsere Dienstleistungen auf die individuellen Anforderungen und Bedürfnisse von Ärztinnen und Ärzte, Pflegende und Klinikleitung ab.

  3. Videos

    Alle anzeigen

  4. www.prnewswire.com › news-releases › halozyme-to-acquireHalozyme to Acquire Antares Pharma to Create a Specialty Product...

    13. Apr. 2022 · Halozyme and Antares Pharma announced a definitive agreement to merge, creating a leading drug delivery and specialty product company. The transaction is expected to be immediately accretive to revenue and non-GAAP earnings in 2022 and to accelerate growth through 2027. The transaction values Antares at $960 million and includes a best-in-class auto injector platform with broad licensing potential.

  5. www.pharmaceutical-technology.com › news › halozyme-acquireHalozyme signs agreement to acquire Antares Pharma for $960m

    14. Apr. 2022 · Halozyme Therapeutics has signed a definitive agreement to buy Antares Pharma, a speciality pharmaceutical firm that develops pharmaceutical products and technologies for targeted therapies. The deal will result in the business combination of Halozyme and Antares to create a drug delivery and speciality product company.

    • Vishnu Priyan

  6. www.prnewswire.com › news-releases › halozyme-completesHalozyme Completes Antares Pharma Acquisition - PR Newswire

    24. Mai 2022 · Halozyme, a biopharmaceutical company, completed its acquisition of Antares Pharma, a biotech company that develops and commercializes injectable drugs and fluids. The merger was completed on May 24, 2022, and Antares ceased to be traded on the NASDAQ Global Select Stock Market. The companies have a history of collaborating on products for various indications and markets.

  7. www.fiercepharma.com › drug-delivery › jj-roche-partnerJ&J, Roche partner Halozyme buys Antares Pharma for $1B, beefing...

    13. Apr. 2022 · Halozyme Therapeutics, a biotech with a subcutaneous drug delivery platform, acquires auto-injector specialist Antares Pharma for about $960 million. The deal combines the two companies’ technologies and expands Halozyme’s commercial portfolio and sales team.

  8. www.linkedin.com › company › antares-pharma-inc-Antares Pharma Inc. | LinkedIn

    Antares Pharma Inc. | 5,146 followers on LinkedIn. Making Medicines Feel Better | About Antares Antares Pharma is a specialty pharmaceutical company that combines drug development expertise with ...